(Q40552244)

21 September 2017

title

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection (English)

1 reference

21 September 2017

main subject

Orthoebolavirus zairense

0 references

Siddhartha Mahanty

1

0 references

Pierre E Rollin

series ordinal

6

object named as

Pierre E Rollin

1 reference

21 September 2017

5

Rafi Ahmed

1 reference

21 September 2017

4

Mike Bray

1 reference

21 September 2017

Manisha Gupta

2

1 reference

21 September 2017

Jason Paragas

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

312

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

415-424

1 reference

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

The Ebola virus VP35 protein functions as a type I IFN antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Initial and innate responses to viral infections--pattern setting in immunity or disease

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

The role of the Type I interferon response in the resistance of mice to filovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

ELISA for the detection of antibodies to Ebola viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Human asymptomatic Ebola infection and strong inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Sensing pathogens and tuning immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Infection and activation of monocytes by Marburg and Ebola viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900233-2

7 January 2021

10.1016/S0042-6822(03)00233-2

Identifiers

DOI

1 reference

21 September 2017

1 reference